Bachrodt Amy bought MAZE
April 1, 2026 · Form 4 insider transaction
Bachrodt Amy bought 2,500 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $26.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$10.42
Total value
$26.1K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after15,465
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.